Pharmaceutical Affairs Act Article 96

Any pharmaceutical firm that advertises a medicament in violation of the provisions set forth in Chapter VII hereof shall be punished in accordance with the applicable provisions of this Chapter, and the competent health authority shall announce in the newspaper the name of the person(s) responsible, the name of the medicament, and the act of violation. In the case of serious violation, the license previously granted to the said medicament may also be revoked, and no application for use of the original name of the said medicament shall be made within a period of two years thereafter.The original competent health authority in charge of medicament advertising shall set a time limit and order the pharmaceutical firm making the illegal advertisement, after its license has been revoked as described in the preceding paragraph, to publish or broadcast via the original mass communication media, an apologetic notice in the same timeframe or same size as that of the illegal advertisement. If the said pharmaceutical firm fails to do so as required, all its previously approved medicament advertisements shall be suspended from publishing or broadcasting, and its further advertising application(s) shall be rejected from the day following the date of expiry of the aforesaid time limit.